COG6 | Component of oligomeric golgi complex 6 | Disease related genes
| | | | | Expressed in all |
COL4A2 | Collagen, type IV, alpha 2 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CORO1A | Coronin, actin binding protein, 1A | Disease related genes Plasma proteins
| | | | | Expressed in all |
COX6B1 | Cytochrome c oxidase subunit VIb polypeptide 1 (ubiquitous) | Disease related genes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
CPT1A | Carnitine palmitoyltransferase 1A (liver) | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CPT2 | Carnitine palmitoyltransferase 2 | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
CSTA | Cystatin A (stefin A) | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enhanced |
CTNNB1 | Catenin (cadherin-associated protein), beta 1, 88kDa | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
CTSD | Cathepsin D | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
CUL4B | Cullin 4B | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
CYB5R3 | Cytochrome b5 reductase 3 | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
CYBA | Cytochrome b-245, alpha polypeptide | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
DAG1 | Dystroglycan 1 (dystrophin-associated glycoprotein 1) | Cytoskeleton related proteins Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
DARS | Aspartyl-tRNA synthetase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
DBT | Dihydrolipoamide branched chain transacylase E2 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
DCXR | Dicarbonyl/L-xylulose reductase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
DDB2 | Damage-specific DNA binding protein 2, 48kDa | Cancer-related genes Disease related genes
| | | | | Expressed in all |
DDOST | Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit (non-catalytic) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
DIABLO | Diablo, IAP-binding mitochondrial protein | Disease related genes Mitochondrial proteins Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
DKC1 | Dyskeratosis congenita 1, dyskerin | Disease related genes Plasma proteins
| | | | | Expressed in all |
DLAT | Dihydrolipoamide S-acetyltransferase | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
DNM1L | Dynamin 1-like | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
DNMT1 | DNA (cytosine-5-)-methyltransferase 1 | Disease related genes Enzymes FDA approved drug targets Plasma proteins Transcription factors
| | | | | Expressed in all |
DSG2 | Desmoglein 2 | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
DYNC1H1 | Dynein, cytoplasmic 1, heavy chain 1 | Disease related genes Plasma proteins
| | | | | Expressed in all |
EFTUD2 | Elongation factor Tu GTP binding domain containing 2 | Disease related genes Plasma proteins
| | | | | Expressed in all |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EIF4A3 | Eukaryotic translation initiation factor 4A3 | Disease related genes Enzymes Plasma proteins Potential drug targets Transporters
| | | | | Expressed in all |
EMD | Emerin | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
ENG | Endoglin | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
EP300 | E1A binding protein p300 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
EPHX1 | Epoxide hydrolase 1, microsomal (xenobiotic) | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ESR1 | Estrogen receptor 1 | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
EWSR1 | EWS RNA-binding protein 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
F2 | Coagulation factor II (thrombin) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
FADD | Fas (TNFRSF6)-associated via death domain | Cancer-related genes Disease related genes
| | | | | Expressed in all |
FAH | Fumarylacetoacetate hydrolase (fumarylacetoacetase) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
FBLN1 | Fibulin 1 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
FGB | Fibrinogen beta chain | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
FHL1 | Four and a half LIM domains 1 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
FKBP10 | FK506 binding protein 10, 65 kDa | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Mixed |
FLG | Filaggrin | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enriched |
FLNA | Filamin A, alpha | Disease related genes Plasma proteins
| | | | | Expressed in all |
FLNB | Filamin B, beta | Disease related genes Plasma proteins
| | | | | Expressed in all |
FN1 | Fibronectin 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
FNBP1 | Formin binding protein 1 | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Expressed in all |
FOXP1 | Forkhead box P1 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
FRYL | FRY-like | Disease related genes
| | | | | Expressed in all |
FTL | Ferritin, light polypeptide | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
FUS | Fused in sarcoma | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |